Exploring CUE-401: A Novel TGF-β/ IL-2 Fusion Protein for the Induction & Expansion of FOXP3+ Regulatory T-Cells
Time: 11:30 am
day: Day 2 Treg Modulators Track AM
Details:
- TGF-β and IL-2 are two key signals for the induction of regulatory T-cell populations
- CUE-401 is a novel TGF-β and IL-2 directed therapy that is being developed for the selective expansion of regulatory T-cells in vivo
- Exploring the activity and mechanism of action of CUE-401
